Wilmington Savings Fund Society FSB Buys 706 Shares of The Clorox Company (NYSE:CLX)

Wilmington Savings Fund Society FSB increased its stake in The Clorox Company (NYSE:CLX) by 6.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,072 shares of the company’s stock after acquiring an additional 706 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Clorox were worth $1,798,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP increased its stake in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock worth $88,315,000 after buying an additional 453,624 shares during the period. International Assets Investment Management LLC raised its holdings in Clorox by 424.9% during the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after buying an additional 435,971 shares during the last quarter. Boston Trust Walden Corp boosted its position in Clorox by 5,442.5% during the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after buying an additional 268,966 shares during the period. Finally, Assenagon Asset Management S.A. grew its holdings in Clorox by 302.0% in the 4th quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock worth $57,390,000 after acquiring an additional 265,455 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.6 %

Shares of Clorox stock opened at $148.51 on Monday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The company has a 50-day moving average of $161.06 and a 200 day moving average of $158.88. The firm has a market cap of $18.38 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the business earned $2.16 earnings per share. As a group, sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 133.33%.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Barclays raised their price target on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.